INTEL CORP ⋅ 10-Q ⋅ 7/24 Philip Morris International Inc. ⋅ 10-Q ⋅ 7/24 TEXAS INSTRUMENTS INC ⋅ 10-Q ⋅ 7/24 AMERICAN EXPRESS CO ⋅ 10-Q ⋅ 7/24 NEXTERA ENERGY INC ⋅ 10-Q ⋅ 7/24 CME GROUP INC. ⋅ 10-Q ⋅ 7/24 KINDER MORGAN, INC. ⋅ 10-Q ⋅ 7/24 TE Connectivity plc ⋅ 10-Q ⋅ 7/24 LAS VEGAS SANDS CORP ⋅ 10-Q ⋅ 7/24 HALLIBURTON CO ⋅ 10-Q ⋅ 7/24

INTEL CORP ⋅ 10-Q ⋅ 7/24 Philip Morris International Inc. ⋅ 10-Q ⋅ 7/24 TEXAS INSTRUMENTS INC ⋅ 10-Q ⋅ 7/24 AMERICAN EXPRESS CO ⋅ 10-Q ⋅ 7/24 NEXTERA ENERGY INC ⋅ 10-Q ⋅ 7/24 CME GROUP INC. ⋅ 10-Q ⋅ 7/24 KINDER MORGAN, INC. ⋅ 10-Q ⋅ 7/24 TE Connectivity plc ⋅ 10-Q ⋅ 7/24 LAS VEGAS SANDS CORP ⋅ 10-Q ⋅ 7/24 HALLIBURTON CO ⋅ 10-Q ⋅ 7/24

Moderna, Inc.

Biological Products, (No Diagnostic Substances) | SIC: 2836
Phone: 6177146500

CIK: 0001682852
EIN: 813467528
State Location: MA
State of Inc.: DE

Nasdaq:MRNA

Form: 4

Filing Date: 08 Jun 2026
Report Date: 05 Jun 2026
Accepted: 08 Jun 2026 02:30 p.m.
Accession Number: 0001682852-26-000117

Act: None
File Number: None
Film Number: None

Documents

Primary Document: PRIMARY DOCUMENT

Accepted: 08 Jun 2026 02:30 p.m.

0001682852-26-000117-index-headers.html

Last Modified: 08 Jun 2026 02:30 p.m.

0001682852-26-000117-index.html

Last Modified: 08 Jun 2026 02:30 p.m.

0001682852-26-000117.txt

Last Modified: 08 Jun 2026 02:30 p.m.

Last Modified: 08 Jun 2026 02:30 p.m.